secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardant Health, Inc. (GH)
CIK:        0001576280
Form:       8-K
Filed at:   2023-04-10T23:59:59+00:00
Accession:  0001576280-23-000049
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardant Health replaces EY with Deloitte as independent auditor; no disagreements cited
--------------------------------------------------------------------------------

- Audit committee approved dismissal of Ernst & Young and engagement of Deloitte effective April 4, 2023.
- EY's audit reports for FY2022 and FY2021 were unqualified with no adverse opinion.
- No disagreements or reportable events occurred during the past two fiscal years or subsequent interim period.
- EY agreed with the disclosures in a letter dated April 10, 2023, filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576280/000157628023000049/0001576280-23-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576280/000157628023000049/gh-20230404.htm
  HTML page:      https://secwatch.observer/filing/0001576280-23-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer